July 21, 2016

Developing new Diagnostics and Therapeutics for an Immune Checkpoint

Investigators: Richard Roberts; Mitchell Gross; Terry Takahashi
July 21, 2016

Optimizing PEOX Formulated C125 for TNBCs

Investigators: Stan Louie; Kathleen Rodgers; Nicos Petasis; Louis Dubeau
March 2, 2016

Bispecific hybrid nanoworms for immunotherapy of B-cell lymphoma

Investigators: J. Andrew MacKay, Ph.D. Peter Conti, M.D., Ph.D., Alan Epstein, M.D., Ph.D. Zibo Li, Ph.D.
Innovation: Nanoworm-delivered therapeutics that can bind to more than one target
Clinical significance: New immunotherapies tailored to non-Hodgkin’s lymphoma patients